Ingrid Söderberg (Former)
1 – 10 of 18
      - show: 10
 - |
 - sort: year (new to old)
 
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2019
 - 
                        Mark
        Lack of Ability to Present Antigens on Major Histocompatibility Complex Class II Molecules Aggravates Atherosclerosis in ApoE-/- Mice
    
    
- Contribution to journal › Article
 
 - 2015
 - 
                        Mark
        IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice.
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout mice.
    
    
- Contribution to journal › Article
 
 - 2012
 - 
                        Mark
        TAP1-Deficiency Does Not Alter Atherosclerosis Development in Apoe(-/-) Mice.
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Increased Inflammation in Atherosclerotic Lesions of Diabetic Akita-LDLr(-/-) Mice Compared to Nondiabetic LDLr(-/-) Mice.
    
    
- Contribution to journal › Article
 
 - 2011
 - 
                        Mark
        Immunization with cationized BSA inhibits progression of disease in ApoBec-1/LDL receptor deficient mice with manifest atherosclerosis.
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine.
    
    
- Contribution to journal › Article
 
 - 2009
 - 
                        Mark
        Effects of simvastatin on circulating autoantibodies to oxidized LDL antigens: relation with immune stimulation markers.
    
    
- Contribution to journal › Article
 
 - 2008
 - 
                        Mark
        Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies.
    
    
- Contribution to journal › Article
 
 - 2007
 - 
                        Mark
        Inhibition of injury-induced arterial remodelling and carotid atherosclerosis by recombinant human antibodies against aldehyde-modified apoB-100.
    
    
- Contribution to journal › Article
 
 
